Addiction Medicine Certification Addiction Medicine Co-occurring Disorders & Dual Diagnosis 2

Question 1

In a patient with schizophrenia and cannabis use disorder, which antipsychotic has the most evidence for reducing cannabis use?

Accepted Answer

Clozapine

Answer

Clozapine has the strongest evidence among antipsychotics for reducing substance use, including cannabis, in patients with schizophrenia.

Question 2

When differentiating substance-induced psychosis from primary psychosis, which timeframe is most commonly used for observation after abstinence?

Accepted Answer

4 weeks

Answer

DSM-5 guidelines suggest that if psychotic symptoms persist beyond 4 weeks of abstinence, a primary psychotic disorder is more likely.

Question 3

Which mood stabilizer is considered first-line for bipolar disorder co-occurring with alcohol use disorder?

Accepted Answer

Valproate (divalproex)

Answer

Valproate (divalproex) has demonstrated efficacy for both bipolar disorder and reduction of alcohol use in patients with co-occurring conditions.

Question 4

Which anxiety disorder has the highest rate of co-occurrence with substance use disorders?

Accepted Answer

Social anxiety disorder

Answer

Social anxiety disorder (social phobia) has the highest prevalence among anxiety disorders co-occurring with substance use disorders, as patients often use alcohol or other substances to manage social situations.

Question 5

A clinician suspects a patient's depression is substance-induced rather than primary. Which finding best supports this conclusion?

Accepted Answer

Depressive symptoms that resolve within weeks of abstinence

Answer

Resolution of depressive symptoms within weeks of achieving abstinence is the hallmark indicator that depression was substance-induced rather than a primary mood disorder.

Addiction Medicine Certification Practice Test

Addiction Medicine Certification Practice Test

Addiction Medicine Certification Addiction Medicine Co-occurring Disorders & Dual Diagnosis 2